(Q50044467)

English

CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.

scientific article published on 8 February 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients. (English)

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

atherosclerosis

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

author name string

Andreas Gille

1

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

Denise D'Andrea

2

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

Michael A Tortorici

3

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

Samuel D Wright

5

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

language of work or name

0 references

publication date

8 February 2018

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

Arteriosclerosis, Thrombosis, and Vascular Biology

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

38

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

4

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

953-963

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Modulating cholesterol efflux capacity to improve cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Prognostic Usefulness of Serum Cholesterol Efflux Capacity in Patients With Coronary Artery Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Serum amyloid A impairs the antiinflammatory properties of HDL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Dysfunctional HDL and atherosclerotic cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

HDL-cholesterol and cardiovascular disease: rethinking our approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

HDL cholesterol efflux capacity and incident cardiovascular events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

A prospective natural-history study of coronary atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 June 2018

High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

16 June 2018

High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

16 June 2018

High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 August 2018

A multiple ascending dose study of CSL112, an infused formulation of ApoA-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 August 2018

High-density lipoprotein apolipoprotein A-I kinetics in obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895137

14 August 2018

Mediterranean diet for primary prevention of cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/29437574

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/29437574

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29437574

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1161/ATVBAHA.118.310538

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

1 reference

Europe PubMed Central

14 June 2018

http://europepmc.org/abstract/PMC/5895137

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50044467&oldid=1477993042"